Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.

September 30, 2026 · 2:32 pm 1 sources

Image: MarketWatch

Coverage

Coverage

• Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
  MarketWatch · September 30, 2026 14:32
  The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.